4 weeks US FDA OKs monthly maintenance dosing for Eisai/Biogen’s Alzheimer’s drug Investing.com

US FDA OKs monthly maintenance dosing for Eisai/Biogen’s Alzheimer’s drug.

Biogen (BIIB) · U.S.